Prior to that approval, Novo Nordisk, which also makes the injectable semaglutide drugs Ozempic and Wegovy, had seen promising results from its trials of the weight-loss pill, which will also be sold under the brand name Wegovy
"We think this addresses and responds to repeated call(s) for lower list prices on the (Capitol) Hill and elsewhere, as well as the call for lower list prices from our patients who want access to these innovative medicines," Millar said
Some Indian brands are approved for both, others for one indication only
The research is clear: optimal glutathione levels protect against aging, chronic disease, and oxidative stress
Bone health is also a concern, especially for women in menopause who are already at risk for bone loss